BEAM
Price
$14.24
Change
-$0.30 (-2.06%)
Updated
Apr 9, 02:09 PM (EDT)
Capitalization
1.45B
34 days until earnings call
EYPT
Price
$4.22
Change
+$0.09 (+2.18%)
Updated
Apr 9, 02:22 PM (EDT)
Capitalization
283.85M
21 days until earnings call
Ad is loading...

BEAM vs EYPT

Header iconBEAM vs EYPT Comparison
Open Charts BEAM vs EYPTBanner chart's image
Beam Therapeutics
Price$14.24
Change-$0.30 (-2.06%)
Volume$100
Capitalization1.45B
EyePoint Pharmaceuticals
Price$4.22
Change+$0.09 (+2.18%)
Volume$7.96K
Capitalization283.85M
BEAM vs EYPT Comparison Chart
Loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
EYPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BEAM vs. EYPT commentary
Apr 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a Hold and EYPT is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 09, 2025
Stock price -- (BEAM: $14.54 vs. EYPT: $4.13)
Brand notoriety: BEAM and EYPT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 158% vs. EYPT: 122%
Market capitalization -- BEAM: $1.45B vs. EYPT: $283.85M
BEAM [@Biotechnology] is valued at $1.45B. EYPT’s [@Biotechnology] market capitalization is $283.85M. The market cap for tickers in the [@Biotechnology] industry ranges from $283.55B to $0. The average market capitalization across the [@Biotechnology] industry is $1.98B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 0 FA rating(s) are green whileEYPT’s FA Score has 1 green FA rating(s).

  • BEAM’s FA Score: 0 green, 5 red.
  • EYPT’s FA Score: 1 green, 4 red.
According to our system of comparison, EYPT is a better buy in the long-term than BEAM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 4 TA indicator(s) are bullish while EYPT’s TA Score has 4 bullish TA indicator(s).

  • BEAM’s TA Score: 4 bullish, 5 bearish.
  • EYPT’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, both BEAM and EYPT are a bad buy in the short-term.

Price Growth

BEAM (@Biotechnology) experienced а -17.55% price change this week, while EYPT (@Biotechnology) price change was -23.80% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -10.34%. For the same industry, the average monthly price growth was -16.04%, and the average quarterly price growth was -19.81%.

Reported Earning Dates

BEAM is expected to report earnings on Aug 12, 2025.

EYPT is expected to report earnings on Jul 30, 2025.

Industries' Descriptions

@Biotechnology (-10.34% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEAM($1.45B) has a higher market cap than EYPT($284M). BEAM YTD gains are higher at: -41.371 vs. EYPT (-44.564). EYPT has higher annual earnings (EBITDA): -129.23M vs. BEAM (-383.98M). BEAM has more cash in the bank: 851M vs. EYPT (371M). EYPT has less debt than BEAM: EYPT (21.9M) vs BEAM (161M). BEAM has higher revenues than EYPT: BEAM (63.5M) vs EYPT (43.3M).
BEAMEYPTBEAM / EYPT
Capitalization1.45B284M511%
EBITDA-383.98M-129.23M297%
Gain YTD-41.371-44.56493%
P/E RatioN/AN/A-
Revenue63.5M43.3M147%
Total Cash851M371M229%
Total Debt161M21.9M735%
FUNDAMENTALS RATINGS
EYPT: Fundamental Ratings
EYPT
OUTLOOK RATING
1..100
54
VALUATION
overvalued / fair valued / undervalued
1..100
62
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
95
P/E GROWTH RATING
1..100
12
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BEAMEYPT
RSI
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
82%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
76%
Momentum
ODDS (%)
N/A
Bearish Trend 1 day ago
87%
MACD
ODDS (%)
N/A
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
89%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 13 days ago
80%
Bullish Trend 17 days ago
84%
Declines
ODDS (%)
Bearish Trend 6 days ago
85%
Bearish Trend 6 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
89%
Aroon
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
88%
View a ticker or compare two or three
Ad is loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
EYPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BRGAX32.10N/A
N/A
iShares Russell 1000 Large-Cap Idx Inv A
FDFIX21.60N/A
N/A
Fidelity Flex 500 Index
FSYMX8.58N/A
N/A
Fidelity Advisor Sustainable Intl Eq M
ETLIX12.34N/A
N/A
Eventide Large Cap Focus I
MCSSX36.03-0.46
-1.26%
NYLI WMC Enduring Capital Investor Class

BEAM and

Correlation & Price change

A.I.dvisor indicates that over the last year, BEAM has been closely correlated with CRSP. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if BEAM jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BEAM
1D Price
Change %
BEAM100%
-4.97%
CRSP - BEAM
72%
Closely correlated
-3.43%
NTLA - BEAM
63%
Loosely correlated
-3.98%
RXRX - BEAM
62%
Loosely correlated
-5.48%
DNLI - BEAM
58%
Loosely correlated
-1.12%
PRME - BEAM
57%
Loosely correlated
-11.54%
More